title: High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation.
authors.forename: Fabio G
authors.initials: FG
authors.lastname: Liberante
authors.forename: Andrea
authors.initials: A
authors.lastname: Pellagatti
authors.forename: Viktoriya
authors.initials: V
authors.lastname: Boncheva
authors.forename: David T
authors.initials: DT
authors.lastname: Bowen
authors.forename: Ken I
authors.initials: KI
authors.lastname: Mills
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Boultwood
authors.forename: Barbara-Ann
authors.initials: BA
authors.lastname: Guinn
mesh_terms: D000951:Antigens, Neoplasm / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D020869:Gene Expression Profiling; D006801:Humans; D053208:Kaplan-Meier Estimate; D009190:Myelodysplastic Syndromes / Q000235:genetics / Q000378:metabolism*
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; C404944:PRAME protein, human
keywords: PReferentially expressed Antigen of the Melanoma Gene; leukaemia antigens; myelodysplastic syndrome; survival; tumour antigens